Did Amazon Just Create a Solution to Pharma’s Last Mile Problem?

| October 31, 2017

article image
Amazon just announced a new program that would allow delivery people into a person’s house. While this may help solve the problem of items being stolen off people’s porches and could make delivery of items that require signatures such as iPhones easier, it may also be another piece to Amazon’s pharma puzzle.As reported in the September 2017 issue of Pharmaceutical Executive, the pharmaceutical industry is at a critical crossroads when it comes to cold chain storage and temperature sensitive items. With more treatment plans including a biologic component, concerns over temperature sensitivity has become paramount.

Spotlight

Teladoc Health

Teladoc Health is the global virtual care leader, offering the only comprehensive virtual care solution spanning telehealth, expert medical, and licensed platform services. Through our award-winning consumer experience brands – Advance Medical, Best Doctors, BetterHelp, HealthiestYou, and Teladoc – we help millions of people around the world resolve their healthcare needs with confidence.

OTHER ARTICLES

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 26, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 26, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 26, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Spotlight

Teladoc Health

Teladoc Health is the global virtual care leader, offering the only comprehensive virtual care solution spanning telehealth, expert medical, and licensed platform services. Through our award-winning consumer experience brands – Advance Medical, Best Doctors, BetterHelp, HealthiestYou, and Teladoc – we help millions of people around the world resolve their healthcare needs with confidence.

Events